Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Psychosis Clinical Trials

A listing of Psychosis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (1073) clinical trials

A clinical research study is underway, evaluating an investigational study drug for adults with Parkinson's Disease who are experiencing a decline in memory and thinking.

Phase

The purpose of this research study is to learn about normal brain function and brain function in various stages of Alzheimer’s disease. There will be 1 baseline visit that will take approximately 7 hours and 1 optional follow up visit (2.5 to 3 years later). Study procedures include PET scans, ...

Phase N/A

Clinical Trials of Texas, Inc. is conducting a research study of an investigational medication for major depressive disorder in teenagers. Qualified participants receive study-related medical care from a board-certified physician, exams and evaluations.

Phase N/A

This is a study for early to mild Alzheimer’s, testing the safety of LY3002813 with or without LY3202626 and any side effects from the study medicine. This study is also evaluating whether LY3002813 with or without LY3202626 can help slow the mental and functional changes of Alzheimer’s disease.

Phase

The purpose of this study is to look into the safety and efficacy of cariprazine in the treatment of Bipolar I disorder. Cariprazine is approved by the U.S. Food and Drug Administration (FDA) and currently licensed in the USA for the acute treatment of manic or mixed episodes associated with bipolar ...

Phase

This study is being done to see whether an investigational drug called LY3303560 is safe and tolerable and whether it might work to help people with Alzheimer’s disease. “Investigational” means that the drug being tested has not been approved for routine clinical use or for the use described in this ...

Phase

The objective of this study is to assess the safety and tolerability of the study drug given orally twice daily for 28 days. The study will also assess the effects of study drug on oral and cerebrospinal fluid biomarkers. The study evaluations include 2 detailed dental examinations and 2 lumbar ...

Phase

If you or someone you love suffers from Mild Cognitive Impairment due to Alzheimer's Disease, or mild Alzheimer's Disease, you may be eligible to participate in a research study.

Phase

ActivMed Practices and Research is looking for volunteers to participate in a device research study on Alzheimer's Disease and memory loss.

Phase N/A